Hong Kong Stock Movement | Maike Medicine-B (02335.HK) Surges Over 28% Again, Has Obtained Ethics Approval from the Lead Site for the Phase III Clinical Trial of MT200605

Zhitong Finance APP has learned that Maike Medicine-B (02335.HK) rose more than 28% again. As of press time, it was up 18.8% at HK$19.32, with a turnover of HK$146 million.